Sintetica
Manufacturing · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Via Penate 5, Mendrisio, Ticino, 6850, S...Phone Number
+41 916404250Website
www.sintetica.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Sintetica
Sintetica is a Swiss pharmaceutical company established in 1921, dedicated to innovating therapies and drugs in anaesthesia, pain management, intensive care, and neuromodulation. The company operates two production sites in Switzerland, specializing in the manufacture of liquid sterile injectable solutions. Sintetica focuses on understanding unmet needs in healthcare to develop novel drug formulations, providing best-in-class solutions to physicians and patients. Committed to corporate social responsibility, Sintetica fosters a culture of respect, inclusion, and environmental protection across its operations.Explore more
Sintetica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sintetica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Sintetica had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Sintetica
Check out if Sintetica is spiking on competitors!
Funding: Get notified immidiatlly once Sintetica has new funding data
Product Launch: Get notified when Sintetica launches new products
Sintetica, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Sintetica recently announced quarterly report
Check if Sintetica has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Sintetica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sintetica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sintetica.
Sintetica Tech Stack
A closer look at the technologies used by Sintetica
See more technologies
Most Recent Scoops
Project
, according to a front-line source in medical, is planning to begin initiatives related to quality management within six to nine months. The organization is currently evaluating various vendors.
Quality Management
Pain Point
, according to a front-line source in medical, is experiencing challenges related to activity-based costing.
Pain Point, Accounting, Finance, Financial Strategy
Pain Point
, according to a front-line source in medical, is experiencing challenges related to medical information systems.
Pain Point, Clinical Systems, Data Management, Enterprise Software, Software, Healthcare Technology
Pain Point
, according to a front-line source in medical, is experiencing challenges related to revenue cycle.
Pain Point, Financial Planning, Healthcare Operations
Pain Point
Pain Point, Collaboration/Web Apps, Employee Relations, Software, Unified Communications, Healthcare Technology
Sintetica News & Media
Sintetica® US Selects FFF Enterprises Inc. as the Exclusive Distributor for Lidocaine Hydrochloride Injection
TEMECULA, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., the nation’s most trusted specialty drug distributor, today announced that it has entered an exclusive partnership with Sintetica® US—a subsidiary of international pharmaceutical company Sintetica S.A.—to provide Lidocaine Hydrochloride Injection, a short-acting amide-type local or regional anesthetic.Sintetica US launches Lidocaine Hydrochloride Injection, USP 1%, 2% and 4%
Lidocaine hydrochloride is a short-acting amide-type local anesthetic with a rapid onset and short duration of action and contains no preservatives. MENDRISIO, Switzerland and PRINCETON, N.J, March 27, 2023 /PRNewswire/ -- Sintetica S.A., an international pharmaceutical company with...Sintetica establishes US entity
MENDRISIO, Switzerland, Oct. 14, 2022 /PRNewswire/ -- Sintetica, a Swiss pharmaceutical company headquartered in Mendrisio specializing in injectables in the field of pain therapy, has taken another important and significant step in its 100-year growth strategy. On July 14, 2022 Sintetica...Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia
NASHVILLE, Tenn. & MENDRISIO, Switzerland--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, and Sintetica, S.A., a growing pharmaceutical company focused on analgesics, local anesthetics, and sterile injectable solutions, today jointly announced the U.S. Food and Drug Administration (FDA) approval of IHEEZO™ (chloroprocaine hydrochloride ophthalmic gel)
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sintetica
Sign Up For FreeTo access detailed company insights
Sintetica is a Swiss pharmaceutical company established in 1921, dedicated to innovating therapies and drugs in anaesthesia, pain management, intensive care, and neuromodulation. The company operates two production sites in Switzerland, specializing in the manufacture of liquid sterile injectable solutions. Sintetica focuses on understanding unmet... Read More
